OAMU
CELG

Ostrum Asset Management US’s Celgene Corp CELG Stock Holding History

Ostrum Asset Management US’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-13,806
Closed -$885K – 243
2018
Q4 		$885K Buy
+13,806
New +$1.02M 0.13% 96

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ostrum Asset Management US's CELG Position: Q1 2019 in Review

Ostrum Asset Management US sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 13,806 shares — an estimated $885K sold.

Ostrum Asset Management US first reported a position in CELG in Q4 2018 and held it in 1 quarter. The position peaked at $885K in Q4 2018. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Ostrum Asset Management US reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Ostrum Asset Management US sold 13,806 Celgene Corp shares in Q1 2019, an estimated $885K.
  • Ostrum Asset Management US first reported a position in Celgene Corp in Q4 2018 and held it in 1 quarter.
  • Ostrum Asset Management US's Celgene Corp position peaked at $885K in Q4 2018.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Ostrum Asset Management US's 13F filing for Q1 2019, filed 15 May 2019.